Literature DB >> 2883346

Hypothyroidism as a cause of acquired von Willebrand's disease.

R G Dalton, M S Dewar, G F Savidge, P B Kernoff, K B Matthews, M Greaves, F E Preston.   

Abstract

Three patients with bleeding tendency who met the criteria for type 1 von Willebrand's disease are described. In two patients, hypothyroidism was suspected and confirmed at presentation, and in the third hypothyroidism became apparent 4 years later. In all three, the history and clinical course after treatment with thyroxine indicated acquired von Willebrand's disease secondary to hypothyroidism. The possibility of hypothyroidism should be considered in patients presenting with von Willebrand's disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2883346     DOI: 10.1016/s0140-6736(87)92272-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  18 in total

1.  Acquired von Willebrand's disease and hypothyroidism: report of a case presenting with menorrhagia.

Authors:  N E Blesing; H Hambley; G A McDonald
Journal:  Postgrad Med J       Date:  1990-06       Impact factor: 2.401

2.  Hypothyroidism and increased bleeding tendency.

Authors:  I B Johnstone
Journal:  Can Vet J       Date:  1988-08       Impact factor: 1.008

Review 3.  Consequences of dysthyroidism on the digestive tract and viscera.

Authors:  Ronald Daher; Thierry Yazbeck; Joe Bou Jaoude; Bassam Abboud
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

Review 4.  von Willebrand disease: clinical and laboratory lessons learned from the large von Willebrand disease studies.

Authors:  Paula D James; David Lillicrap
Journal:  Am J Hematol       Date:  2012-03-03       Impact factor: 10.047

Review 5.  Haemostasis in hypothyroidism.

Authors:  H C Ford; J M Carter
Journal:  Postgrad Med J       Date:  1990-04       Impact factor: 2.401

6.  Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism.

Authors:  Cihangir Erem; Ozge Ucuncu; Mustafa Yilmaz; Mustafa Kocak; Irfan Nuhoglu; Halil Onder Ersoz
Journal:  Endocrine       Date:  2008-10-29       Impact factor: 3.633

Review 7.  Acquired von Willebrand syndrome: its pathophysiology, laboratory features and management.

Authors:  Hiroshi Mohri
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300

8.  The role of the 5'-flanking region in the cell-specific transcription of the human von Willebrand factor gene.

Authors:  V Ferreira; Z Assouline; J L Schwachtgen; B R Bahnak; D Meyer; D Kerbiriou-Nabias
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

Review 9.  The molecular characterization of von Willebrand disease: good in parts.

Authors:  P D James; D Lillicrap
Journal:  Br J Haematol       Date:  2013-02-14       Impact factor: 6.998

Review 10.  The coagulation system in endocrine disorders: a narrative review.

Authors:  A Squizzato; V E A Gerdes; W Ageno; H R Büller
Journal:  Intern Emerg Med       Date:  2007-07-09       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.